Small platelet microparticle levels are increased in pulmonary arterial hypertension

European Journal of Clinical Investigation

Volumn 43, Issue 1, 2013, Pages 64-71

  Nadaud, Sophie ^a,b,c   Poirier, Odette ^a,b,c   Girerd, Barbara ^d,e,f   Blanc, Catherine ^b,g   Montani, David ^d,e,f   Eyries, Mélanie ^a,c,g   Imbert Bismut, Françoise ^g   Pacheco, Antoine ^h   Vigne, Jacques ^h   Tregouet, David Alexandre ^b,c,i   Humbert, Marc ^d,e,f   Soubrier, Florent ^a,b,c,g  

^a Institute OfCardiometabolism and Nutrition   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ICAN Institute for Cardiometabolism and Nutrition   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e BICÊTRE HOSPITAL   (France)

^f Universite Paris Sud   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h BECKMAN COULTER INC   (United States)

ⁱ INSERM   (France)

Author keywords

Associated pulmonary hypertension; Endothelial microparticles; Flow cytometry; Heritable pulmonary hypertension; Idiopathic pulmonary hypertension; Platelet microparticles

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CD31 ANTIGEN; FIBRINOGEN RECEPTOR;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEX DIFFERENCE; THROMBOCYTE;

ADULT; AGED; BLOOD PLATELETS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; LINEAR MODELS; MALE; MIDDLE AGED;

EID: 84872068000     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12018     Document Type: Article

References (34)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
2. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S-24S.
3. Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, Nana-Sinkam SP et al. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;170:911-19.
4. Geraci MW, Moore M, Gesell T, Yeager ME, Alger L, Golpon H et al. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 2001;88:555-62.
5. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005;288:H1004-9.
6. Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 2006;95:94-9.
7. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007;137:36-48.
8. Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A et al. Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2008;177:536-43.
9. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1268-75.
10. Diehl P, Aleker M, Helbing T, Sossong V, Germann M, Sorichter S et al. Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension. J Thromb Thrombolysis 2011;31:173-9.
11. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63.
12. Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 2008;177:1377-83.
13. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?J Thromb Haemost 2009;7:190-7.
14. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002;51:2840-5.
15. Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jais X et al. Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation. Am J Respir Crit Care Med 2010;181:851-61.
16. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16:3381-8.
17. Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009;102:711-18.
18. Pelletier F, Garnache-Ottou F, Angelot F, Biichle S, Vidal C, Humbert P et al. Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis. J Invest Dermatol 2011;131:1573-6.
19. Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C et al. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles--brief report. Arterioscler Thromb Vasc Biol 2012;32:1054-8.
20. Skeppholm M, Mobarrez F, Malmqvist K, Wallen H. Platelet derived microparticles during and after acute coronary syndrome. Thromb Haemost 2012;107:1122-9.
21. Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?Arterioscler Thromb Vasc Biol 2011;31:4-9.
22. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009;54:S10-19.
23. Johnson SR, Granton JT, Mehta S. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest 2006;130:545-52.
24. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010;8:2358-68.
25. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991;77:2641-8.
26. Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Yao Y, Mason KD et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009;114:663-6.
27. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93-102.
28. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011;109:593-606.
29. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2008;118:2372-9.
30. Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC. Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. Am J Respir Crit Care Med 2010;182:261-8.
31. Weber A, Koppen HO, Schror K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000;98:461-6.
32. Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004;43:428-33.
33. Lok CA, Van Der Post JA, Sargent IL, Hau CM, Sturk A, Boer K et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:344-60.
34. Navasiolava NM, Dignat-George F, Sabatier F, Larina IM, Demiot C, Fortrat JO et al. Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers. Am J Physiol Heart Circ Physiol 2010;299:H248-56.